News

Fintel reports that on July 1, 2025, Lake Street initiated coverage of Aytu BioPharma (NasdaqCM:AYTU) with a Buy ...
Fintel reports that on June 30, 2025, Ascendiant Capital initiated coverage of Aytu BioPharma (NasdaqCM:AYTU) with a Buy ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...